We are a Swiss law firm, dedicated to providing legal solutions to business, tax and regulatory matters.
SWISS LAW AND TAX
Services
Intellectual Property
Life Sciences, Pharma, Biotech
Litigation and Arbitration
Meet our team
Our knowledge, expertise & publications
View all
Events
Deals & Cases
Careers
22 November 2021
RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF) ("Relief"), a biopharmaceutical company, has launched its Level 1 American Depositary Receipt ("ADR") program in the United States. As of 18 November 2021, ADRs may be traded over the counter. Relief's ADR program complements its existing primary listing of shares on the SIX Swiss Exchange. J.P. Morgan has been appointed as the depositary bank for the ADR program.
VISCHER advised Relief on the Swiss legal aspects under this ADR program. The VISCHER team led by partner Dr. Robert Bernet (Corporate/M&A) comprised Dr. Peter Kühn (Counsel, Corporate/M&A), Christian Schneiter (Senior Associate, Corporate/M&A) and Christoph Niederer (Partner, Tax).
Categories: Mergers & Acquisitions, Tax
Attorney at Law
Attorney at Law, Swiss Certified Tax Expert
The software company Infosim GmbH & Co. KG, based in Würzburg, a leading international provider of...
Bernet, Robert / Kühn, Peter, Wer trägt die Finanzierungsverantwortung?, WEKA Business Media AG, Nr....
RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFFD, RLFTD) ("Relief") has entered into has...